ClinicalTrials.gg
RecruitingNCT05897164Updated Aug 20, 2026

Mobile Technology to Reduce Teen Substance Misuse

An interventional study of WisePath for Teens and Peer Support Services (PSS) in Substance Use, Substance Abuse and Suicide, sponsored by Evidence-Based Practice Institute, Seattle, WA. Recruiting at 2 sites in United States. Open to participants aged 13 Years and older. Per ClinicalTrials.gov, last updated 2026-08-20.

Sponsored by Evidence-Based Practice Institute, Seattle, WA · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Aug 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
600
Allocation
Randomized
Ages
13 Years and older
Sex
All
01

Study summary

The goal of this study is to test the newly expanded WisePath for Teens (WPT) for substance use app, a direct-to-consumer paired mobile phone app for iOS and Android platforms that supports parents/guardians in delivering evidence-based techniques to reduce youth substance abuse and co-occurring mental health problems. This project will expand WPT for use with a general population of teens with problematic substance use and their parents to reduce substance abuse, its harmful effects, opioid overdoses, and progression to substance use disorders, as well as other behavioral health problems that are exacerbated by substance abuse and/or interfere with substance abuse treatment.

Read the detailed description

This project will test the newly expanded WisePath for Teens (WPT), a paired mobile app to support parents delivering, and youth receiving, evidence-based practices to reduce youth's substance abuse (SA) and other significant behavioral health problems that commonly co-occur with SA, exacerbate SA, and/or interfere with youth's treatment. Through a collaborative "discussion" with a chatbot, WPT will collect information about the youth's substance use and other behavioral health problems, utilizing methods designed to enhance motivation and engagement. Using a shared decision-making process, WPT will configure to address the youth's specific SA triggers and functions and other identified top problems (e.g., depression, stress, insomnia). The platform will generate recommended parent- and family-focused strategies for the parent app and will use the parent-teen interactive card system to deliver evidence-based family therapy tasks, tailoring parent notifications to match specific teen risks.

This study includes a 12-week randomized controlled trial (RCT) with 300 youth participants aged 13-17 years and their primary caregiver (dyads). Dyads will be randomly assigned to use WisePath for Teens (WPT; n=100 dyads), WisePath for Teens plus parental support by an assigned peer support specialist (WPT+PSS; n=100 dyads), or an active control condition involving access to a webpage of resources relating to substance use and general stress reduction; presented resources are updated every 2-3 days (Control; n=100 dyads). We will also provide simple instructions on how to save the webpage to their phone's home screen (similar to an app icon) to make access easier and more like accessing an installed mobile app. Youth participants will be matched across condition on age and substance use severity. Participants will be assessed at three time points: baseline, one intermediate time point (at either 4 weeks or 8 weeks), and 12 weeks.

The study uses a Planned Missingness Design that assesses change over time for each participant across three time points spread across four assessment opportunities lasting a total of 12 weeks. Specifically, each study participant will complete measures at baseline and also at 12 weeks; each family dyad will be randomly assigned to also complete one additional assessment at either week 4 or week 8. We predict that participants in both WPT conditions will report significantly greater decreases in substance use and associated risky behaviors, greater decreases in stress, greater increases in capacity for coping with distress, and superior satisfaction ratings compared to control participants. We predict in comparison to WPT use alone, those in the enhanced condition will have superior outcomes across all measures.

Primary youth-reported outcomes include: substance use and related problems (school and crime/violence); recovery environment quality; mental health (internalizing and externalizing symptoms), and family functioning (conflict, involvement). Primary caregiver-reported outcome variables include: family functioning (conflict, involvement), parenting skills (monitoring/supervision, discipline consistency, positivity), and parenting cognitions (perceived stress and efficacy). Caregivers will also report on youth mental health symptoms. App satisfaction and use of technology outcomes (i.e., degree of app usage, features used) will be examined as between-groups differences for WPT vs. WPT+PSS arms, as well as potential predictors of changes across time in caregiver and youth outcomes.

02

Conditions studied

  • Substance Use
  • Substance Abuse
  • Suicide
  • Adolescent
03

In context

Substance-Related Disorders

2,238 studies on the registry are indexed under Substance-Related Disorders; 409 are open to participants now.

This study's planned enrollment of 600 is above the median of 108 across 1,840 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Evidence-Based Practice Institute, Seattle, WA is the lead sponsor of 8 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Youth:

  • Resides in United States
  • 13-17 years of age
  • Fluent in English
  • Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan that they use on a daily basis
  • Currently residing in the same household with the linked caregiver/legal guardian participant at least five days a week
  • Meets criteria for mild-moderate or severe SA (for any drug or alcohol) on the Screening to Brief Intervention (S2BI), indicated by answering that they have used any substance at least once per month within the past 90 days.
  • Possesses and is the primary user of an Android or iPhone-based smartphone with a data plan

Caregivers:

  • Resides in United States
  • 18 years or older
  • Fluent in English
  • Owns and is the primary user of an Android or iPhone-based smartphone with a data plan that they use on a daily basis
  • Able and willing to receive and send several (1-3 times/week) text messages from study staff during study participation
  • Is the primary caregiver of a youth aged 13-17 years who lives in the caregiver's home at least five days a week
  • Caregiver indicates a substance concern for the target youth, defined as either a+b OR c:

    1. uses alcohol, marijuana, and/or another substance, AND
    2. expresses that they are concerned (a score of 3 or higher) about that use on a 5-pt Likert scale (3 = concerned, 4 = very concerned, 5 = extremely concerned).

      OR

    3. The target youth participated in counseling or another form of treatment (e.g., medication assisted treatment) because of a concern about alcohol, marijuana, or other substance use.

Exclusion criteria

EXCLUSION CRITERIA

Youth:

  • Participated in previous iKinnect or WisePath for Teens research in the past 2 years

Caregivers:

  • Participated in previous iKinnect or WisePath for Teens research in the past 2 years
  • Currently involved with the child protective service system due to a concern about child maltreatment (i.e., abuse or neglect).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Investigator)
Enrollment
600 participants (estimated)

Study arms

  • Experimental
    WPT

    Youth and parents allocated to the WPT condition will use WPT, a newly developed app to support parents delivering (and for youth, receiving) evidence-based practices to reduce youth's substance abuse and other significant behavioral health problems that commonly co-occur with substance abuse, exacerbate substance abuse and/or interfere with their treatment.

    Other: WisePath for Teens

  • Experimental
    WPT + PSS

    Youth and parents allocated to the WPT + PSS condition will use WPT paired with a family peer support specialist.

    Other: WisePath for Teens · Behavioral: Peer Support Services (PSS)

  • Active comparator
    WILLOW

    Caregivers and teens allocated to the control condition will each be provided with access to the study-developed webpage that has links to freely-available, online, high-quality resources related to teen substance use and general stress reduction, with all links tailored to each webpage's intended audience (i.e., caregivers will be given links to parent-facing resources and teens will be given links to teen-facing or teen-appropriate webpages and resources). Dyads will receive simple instructions on how to save the webpage to their phone's home screen (similar to an app icon) to make access easier and more like accessing an installed mobile app.

    Device: Control

Interventions

  • OtherWisePath for Teens

    WPT is a paired mobile phone app for use on both Android and iOS operating systems by youth experiencing SA and their parents/guardians.

    Also known as: WPT

  • BehavioralPeer Support Services (PSS)

    PSS are provided by people with lived experience with histories of adolescent substance abuse and are now in recovery who are also certified as peer support specialists. A specialist will virtually (e.g., over the phone, screensharing) meet with families regularly to provide support and ensure that families are able to use iKinnect-SA and access the app's features.

  • DeviceControl

    Website with icon on participant's phone with Android or iOS operating systems.

    Also known as: WILLOW

06

What researchers measure

Primary outcomes

  1. Change in Timeline Followback Method Assessment (TLFB)

    The TLFB assesses use of alcohol and 13 different drugs over the past 30 days. It involves asking clients to retrospectively estimate their drug, marijuana or cigarette use.

    Time frame: Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

  2. Change in Global Assessment of Individual Needs-Q3 (GAIN)

    Scales from GAIN specifically identify and address substance use frequency (3 items), substance problems (5 items), crime/violence (5 items), and recovery environment risk (9 items) and are well-validated for adolescents.

    Time frame: Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

  3. Change in Achenbach (Child/Adult) Behavior Checklist

    A widely used 123-item caregiver report form used to assess youth behavioral and emotional problems.

    Time frame: Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

  4. Change in Family Environment Scale (FES)

    A widely-used measure of family conflict (12 items) and cohesion (15 items).

    Time frame: Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

  5. Change in Parent-Adolescent Relationship Scale (PARS)

    A 15-item reliable measure of parent-teen connectedness, hostility, and involvement.

    Time frame: Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

  6. Change in Alabama Parenting Questionnaire (APQ)

    A psychometrically sound measure of positive parenting (6 items), monitoring/supervision (10 items), and discipline consistency (6 items).

    Time frame: Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

  7. Change in Perceived Stress Scale (PSS)

    A reliable 10-item measure to assess parents' overall stress in parenting over the past two weeks.

    Time frame: Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

  8. Change in Parent Locus of Control (PLC)

    A scale to measure parents' feelings of helplessness (10 items) and efficacy in dealing with parenting challenges (10 items).

    Time frame: Baseline (Time 1), 1-4 weeks (Time 2), 5-8 weeks (Time 3), and 9-12 weeks (Time 4)

  9. App Satisfaction Survey

    An 8-item survey used in EBPI's previous research and focuses on the app's ease of use and helpfulness on a five-point rating scale. The survey also captures an overall satisfaction rating for the app used on a 100-point scale.

    Time frame: 9-12 weeks (Time 4)

Other outcomes

  1. Demographics Questionnaire

    Self-report measure to collect demographics from participants in this study. Questions include items about gender, race, and ethnicity.

    Time frame: Eligibility Screening

  2. Screening to Brief Intervention (S2BI) scale

    8-item scale assessing the frequency and severity of use with 90% and 94% sensitivity to detect moderate to severe SA, respectively.

    Time frame: Eligibility Screening

07

Study locations

2 of 2 sites recruiting
  • University of Maryland, Baltimore
    Baltimore, Maryland 21201, United States
    Recruiting
    • Cindy Schaeffer, PhD · Principal investigator
  • Evidence-Based Practice Institute
    Seattle, Washington 98126, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — The final dataset will include self-reported demographic and behavioral data from youth and parent/guardian participants in the randomized controlled trial. The dataset will include sensitive data from youth participants aged 13-17 years regarding substance use, suicidal behavior, and other behavioral health problems. Thus, the de-identified dataset will be distributed by Drs. Dimeff and Schaeffer to those that request it and only under a data-sharing agreement that includes: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate security protections; and (3) a commitment to destroying the data after analyses are completed.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: These materials will become available upon completion of study analyses.

Access criteria: The de-identified dataset will be distributed only under a data-sharing agreement that includes: (1) a commitment to using the data only for research purposes and not to identify any individual participant; (2) a commitment to securing the data using appropriate security protections; and (3) a commitment to destroying the data after analyses are completed.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2026 (actual). Primary completion is estimated for Nov 2026, 3 months after the start.

Of 40 industry-sponsored interventional studies with no phase under Substance-Related Disorders, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 48. This study's planned 3 months is below that.

Counting every sponsor, half of 854 studies reached it within 34 months; a quarter within 17 and three quarters within 53.

How these figures are worked out, and which studies are left out of them.

Registered
May 22, 2023
First posted
Jun 9, 2023
StartActual
Aug 18, 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Apr 30, 2027
Last update
Aug 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05897164
Lead sponsor
Evidence-Based Practice Institute, Seattle, WA
Responsible party
Sponsor
First posted
Jun 9, 2023
Start date
Aug 18, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Apr 30, 2027 (estimated)
Last update
Aug 20, 2026

Study contacts

Samantha Daniels
Contact
clinicaltrials@ebpi.org
206-455-7934
Angela Kelley Brimer, MS
Contact
clinicaltrials@ebpi.org
206-455-7934
Linda Dimeff, PhD
principal investigator · Chief Scientific Officer, Evidence-Based Practice Institute
Cindy Schaeffer, PhD
principal investigator · Associate Professor, University of Maryland-Baltimore

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion